Serum

SII’s Phase-2 and 3 clinical trials of Covovax will reportedly be conducted in 920 children — 460 each in 12-17 years and 2-11 years groups, media reports said…reports Asian Lite News The

Says SII has delivered more than 200 million doses, even though it received Emergency Use Authorisation two months after US pharma companies did, reports Asian Lite News Serum Institute of India (SII)